Ernexa Therapeutics (ERNA) EBITDA Margin (2009 - 2026)
Ernexa Therapeutics' EBITDA Margin was -14094.74% in Q4 2024, down 2374.33 percentage points from -11720.41% a year earlier and down 13638.47 percentage points from the prior quarter.
Powered by 
Analysis
Ernexa Therapeutics (ERNA) EBITDA Margin (2009 - 2026) Analysis & Trends
For FY2024, EBITDA Margin at Ernexa Therapeutics came in at -2589.17%, up 18461.83 percentage points from FY2023.
- EBITDA Margin shows a five-year change of -2594.80 percentage points (FY2019 to FY2024).
- In earlier years, EBITDA Margin was -21051.00% in FY2023 and -123.28% in FY2020 (-128.91 pp).
- The Q4 2024 figure marks the lowest quarterly EBITDA Margin in data going back to Q2 2010.
- Per Business Quant data, ERNA's EBITDA Margin in the three quarters before Q4 2024 was -456.26% (Q3 2024), -10397.87% (Q2 2024) and -12229.79% (Q1 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 36.69% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 40.60% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 39.77% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 42.49% |
| 10 | Ernexa Therapeutics | 3.31 Mn | -18.41 Mn | - | -6,081.63% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -6,081.63% |
| Jun 30, 2026 | -7,445.45% |
| Mar 31, 2026 | -12,686.36% |
| Sep 30, 2025 | -6,374.19% |
| Mar 31, 2025 | -54,240.00% |
| Dec 31, 2024 | 2,278.95% |
| Sep 30, 2024 | -203.90% |
| Jun 30, 2024 | -9,389.36% |
| Mar 31, 2024 | -11,282.98% |
| Dec 31, 2023 | -11,208.16% |
| Sep 30, 2023 | -10,754.90% |
| Jun 30, 2023 | -18,866.67% |
| Dec 31, 2020 | -185.50% |
| Sep 30, 2020 | -134.01% |
| Jun 30, 2020 | -263.74% |
| Mar 31, 2020 | -41.29% |
| Dec 31, 2019 | -10.43% |
| Sep 30, 2019 | 9.24% |
| Jun 30, 2019 | 13.53% |
| Mar 31, 2019 | 11.03% |
API Access
Ernexa Therapeutics EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ERNA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "ERNA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ERNA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();